14-23386640-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002471.4(MYH6):​c.4651-17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.275 in 1,461,826 control chromosomes in the GnomAD database, including 53,508 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4408 hom., cov: 30)
Exomes 𝑓: 0.28 ( 49100 hom. )

Consequence

MYH6
NM_002471.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.10

Publications

7 publications found
Variant links:
Genes affected
MYH6 (HGNC:7576): (myosin heavy chain 6) Cardiac muscle myosin is a hexamer consisting of two heavy chain subunits, two light chain subunits, and two regulatory subunits. This gene encodes the alpha heavy chain subunit of cardiac myosin. The gene is located approximately 4kb downstream of the gene encoding the beta heavy chain subunit of cardiac myosin. Mutations in this gene cause familial hypertrophic cardiomyopathy and atrial septal defect 3. [provided by RefSeq, Feb 2017]
MYH6 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 14
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • Keppen-Lubinsky syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial septal defect 3
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 14-23386640-C-T is Benign according to our data. Variant chr14-23386640-C-T is described in ClinVar as Benign. ClinVar VariationId is 258711.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.349 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH6NM_002471.4 linkc.4651-17G>A intron_variant Intron 32 of 38 ENST00000405093.9 NP_002462.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH6ENST00000405093.9 linkc.4651-17G>A intron_variant Intron 32 of 38 5 NM_002471.4 ENSP00000386041.3

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
35818
AN:
150064
Hom.:
4403
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.363
Gnomad AMR
AF:
0.243
Gnomad ASJ
AF:
0.342
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.363
Gnomad FIN
AF:
0.222
Gnomad MID
AF:
0.348
Gnomad NFE
AF:
0.256
Gnomad OTH
AF:
0.280
GnomAD2 exomes
AF:
0.249
AC:
59829
AN:
240322
AF XY:
0.260
show subpopulations
Gnomad AFR exome
AF:
0.187
Gnomad AMR exome
AF:
0.173
Gnomad ASJ exome
AF:
0.328
Gnomad EAS exome
AF:
0.178
Gnomad FIN exome
AF:
0.216
Gnomad NFE exome
AF:
0.264
Gnomad OTH exome
AF:
0.268
GnomAD4 exome
AF:
0.279
AC:
366391
AN:
1311638
Hom.:
49100
Cov.:
34
AF XY:
0.282
AC XY:
184800
AN XY:
654186
show subpopulations
African (AFR)
AF:
0.203
AC:
6097
AN:
30038
American (AMR)
AF:
0.187
AC:
7956
AN:
42556
Ashkenazi Jewish (ASJ)
AF:
0.349
AC:
8137
AN:
23336
East Asian (EAS)
AF:
0.201
AC:
6949
AN:
34650
South Asian (SAS)
AF:
0.360
AC:
29508
AN:
81986
European-Finnish (FIN)
AF:
0.242
AC:
11319
AN:
46856
Middle Eastern (MID)
AF:
0.350
AC:
1866
AN:
5332
European-Non Finnish (NFE)
AF:
0.282
AC:
279717
AN:
993224
Other (OTH)
AF:
0.277
AC:
14842
AN:
53660
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.430
Heterozygous variant carriers
0
11581
23161
34742
46322
57903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9446
18892
28338
37784
47230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
35850
AN:
150188
Hom.:
4408
Cov.:
30
AF XY:
0.238
AC XY:
17506
AN XY:
73406
show subpopulations
African (AFR)
AF:
0.190
AC:
7789
AN:
41014
American (AMR)
AF:
0.243
AC:
3677
AN:
15138
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
1183
AN:
3456
East Asian (EAS)
AF:
0.188
AC:
937
AN:
4996
South Asian (SAS)
AF:
0.363
AC:
1686
AN:
4642
European-Finnish (FIN)
AF:
0.222
AC:
2241
AN:
10086
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.256
AC:
17320
AN:
67582
Other (OTH)
AF:
0.284
AC:
592
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1279
2558
3837
5116
6395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.247
Hom.:
918
Bravo
AF:
0.234
Asia WGS
AF:
0.261
AC:
908
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 14 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.054
DANN
Benign
0.76
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071634; hg19: chr14-23855849; COSMIC: COSV62449567; COSMIC: COSV62449567; API